Literature DB >> 24327321

Rare combination of myasthenia and motor neuronopathy, responsive to Msc-Ntf stem cell therapy.

Panayiota Petrou1, Avizohar Argov, Vanda A Lennon, Marc Gotkine, Ibrahim Kassis, Adi Vaknin-Dembinsky, Tamir Ben-Hur, Daniel Offen, Oded Abramsky, Eldad Melamed, Dimitrios Karussis.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24327321     DOI： 10.1002/mus.24143

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN： 0148-639X            Impact factor:   3.217


× No keyword cloud information.
  5 in total

Review 1.  Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases.

Authors:  Nathan P Staff; David T Jones; Wolfgang Singer
Journal:  Mayo Clin Proc       Date:  2019-05       Impact factor: 7.616

2.  Amyotrophic Lateral Sclerosis and Myasthenia Gravis Overlap Syndrome: A Review of Two Cases and the Associated Literature.

Authors:  Hongfei Tai; Liying Cui; Yuzhou Guan; Mingsheng Liu; Xiaoguang Li; Yan Huang; Jing Yuan; Dongchao Shen; Dawei Li; Feifei Zhai
Journal:  Front Neurol       Date:  2017-05-22       Impact factor: 4.003

Review 3.  Stem Cell Therapy in Neuroimmunological Diseases and Its Potential Neuroimmunological Complications.

Authors:  Franz Felix Konen; Philipp Schwenkenbecher; Konstantin Fritz Jendretzky; Stefan Gingele; Lea Grote-Levi; Nora Möhn; Kurt-Wolfram Sühs; Britta Eiz-Vesper; Britta Maecker-Kolhoff; Corinna Trebst; Thomas Skripuletz; Martin W Hümmert
Journal:  Cells       Date:  2022-07-11       Impact factor: 7.666

4.  Safety of repeated transplantations of neurotrophic factors-secreting human mesenchymal stromal stem cells.

Authors:  Yael Gothelf; Natalie Abramov; Adrian Harel; Daniel Offen
Journal:  Clin Transl Med       Date:  2014-07-10

5.  Dental follicle mesenchymal stem cell administration ameliorates muscle weakness in MuSK-immunized mice.

Authors:  Canan Ulusoy; Noushin Zibandeh; Selin Yıldırım; Nikolaos Trakas; Paraskevi Zisimopoulou; Melike Küçükerden; Hatice Tașlı; Socrates Tzartos; Kamil Göker; Erdem Tüzün; Tunç Akkoç
Journal:  J Neuroinflammation       Date:  2015-12-09       Impact factor: 8.322
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.